Variables influencing platelet function analyzer-100TM closure times in healthy individuals

被引:58
作者
Haubelt, H [1 ]
Anders, C [1 ]
Vogt, A [1 ]
Hoerdt, P [1 ]
Seyfert, UT [1 ]
Hellstern, P [1 ]
机构
[1] Acad City Hosp, Inst Hemostaseol & Transfus Med, D-67063 Ludwigshafen, Germany
关键词
platelet function analyzer 100; reference ranges; bleeding time; platelet function tests; von Willebrand factor;
D O I
10.1111/j.1365-2141.2005.05680.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the relationship between platelet function analyzer (PFA-100 (TM) ) closure times (CT) and bleeding time (BT), platelet aggregation (PA) induced by ADP, arachidonic acid, and collagen, blood cell counts, and von Willebrand factor (VWF) in 120 well-characterised healthy individuals. Preanalytical and analytical conditions were standardised comprehensively. In a substantial number of cases the differences between duplicate measurements exceeded 15%. The reference range (5th and 95th percentiles) for CT with the collagen/epinephrine (CEPI) and the collagen/ADP (CADP) cartridge was 93-223 s and 64-117 s respectively. Re-examination of 11 individuals with CEPI-CT above the 95th percentile revealed considerable batch-to-batch variation of CEPI-CT. Males had significantly longer CADP than females (P = 0.002). CEPI and CADP-CT measured Pm were significantly longer than corresponding values determined AM (P = 0.003 and P < 0.0001 respectively). Blood group 0 was associated with greater CEPI and CADP-CT and lower VWF levels compared with non-O blood groups (P = 0.008, P = 0.0003 and P < 0.0001 respectively). Linear regression analysis revealed association between CEPI-CT, CADP-CT and VWF (P < 0.0001), but no relationship was found between CT and BT or between CT and PA. We conclude that VWF plasma levels modulate PFA-100 (TM) CT to a greater extent than platelet function. Establishment of reliable reference ranges and careful standardisation of pre-analytical and analytical conditions is a prerequisite for obtaining reliable PFA-100 (TM) results. Duplicate measurements are necessary.
引用
收藏
页码:759 / 767
页数:9
相关论文
共 39 条
[11]   Screening for von Willebrand disease with a new analyzer using high shear stress: A study of 60 cases [J].
Fressinaud, E ;
Veyradier, A ;
Truchaud, F ;
Martin, I ;
Boyer-Neumann, C ;
Trossaert, M ;
Meyer, D .
BLOOD, 1998, 91 (04) :1325-1331
[12]   Profile and prevalence of aspirin resistance in patients with cardiovascular disease [J].
Gum, PA ;
Kottke-Marchant, K ;
Poggio, EC ;
Gurm, H ;
Welsh, PA ;
Brooks, L ;
Sapp, SK ;
Topol, EJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (03) :230-235
[13]   High incidence of defective high-shear platelet function among platelet donors [J].
Harrison, P ;
Segal, H ;
Furtado, C ;
Verjee, S ;
Sukhu, K ;
Murphy, ME .
TRANSFUSION, 2004, 44 (05) :764-770
[14]   The PFA-100®:: a potential rapid screening tool for the assessment of platelet dysfunction [J].
Harrison, P ;
Robinson, M ;
Liesner, R ;
Khair, K ;
Cohen, H ;
Mackie, I ;
Machin, S .
CLINICAL AND LABORATORY HAEMATOLOGY, 2002, 24 (04) :225-232
[15]   Performance of the platelet function analyser PFA-100® in testing abnormalities of primary haemostasis [J].
Harrison, P ;
Robinson, MSC ;
Mackie, IJ ;
Joseph, J ;
McDonald, SJ ;
Liesner, R ;
Savidge, GF ;
Pasi, J ;
Machin, SJ .
BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (01) :25-31
[16]  
Harrison Paul, 2004, Methods Mol Biol, V272, P215
[17]   CIRCADIAN VARIATIONS IN BLOOD-COAGULATION PARAMETERS, ALPHA-ANTITRYPSIN ANTIGEN AND PLATELET-AGGREGATION AND RETENTION IN CLINICALLY HEALTHY-SUBJECTS [J].
HAUS, E ;
CUSULOS, M ;
SACKETTLUNDEEN, L ;
SWOYER, J .
CHRONOBIOLOGY INTERNATIONAL, 1990, 7 (03) :203-216
[18]   Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100(TM) system [J].
Heilmann, EJ ;
Kundu, SK ;
Sio, R ;
Garcia, C ;
Gomez, R ;
Christie, DJ .
THROMBOSIS RESEARCH, 1997, 87 (01) :159-164
[19]   Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction [J].
Jilma, B .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2001, 138 (03) :152-163
[20]   Impaired platelet function among platelet donors [J].
Jilma-Stohlawetz, P ;
Hergovich, N ;
Homoncik, M ;
Dzirlo, L ;
Horvath, M ;
Janisiw, M ;
Panzer, S ;
Jilma, B .
THROMBOSIS AND HAEMOSTASIS, 2001, 86 (03) :880-886